Temporary Spinal Cord Stimulation to Prevent Postcardiac Surgery Atrial Fibrillation
Authors:
- Alexander RomanovARAlexander Romanov
- Vladimir LomivorotovVLVladimir Lomivorotov
- Alexander ChernyavskiyACAlexander Chernyavskiy
- Vladimir MurtazinVMVladimir Murtazin
- Elena KliverEKElena Kliver
- Dmitry PonomarevDPDmitry Ponomarev
- Igor MikheenkoIMIgor Mikheenko
- Alexander YakovlevAYAlexander Yakovlev
- Marina YakovlevaMYMarina Yakovleva
- Jonathan S. SteinbergJSJonathan S. Steinberg
Abstract
No abstract availableFunding Information
- Allergan
- Boston Scientific Corporation (ISRRM10344)
- National Institutes of Health (NCT03539354)
- Ministry of Health of the Russian Federation (121031300225-8)
- Medtronic
This publication has 3 references indexed in Scilit:
- Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: Three-year follow-up of a randomized studyHeart Rhythm, 2019
- Spinal cord stimulation suppresses atrial fibrillation by inhibiting autonomic remodelingHeart Rhythm, 2016
- Spinal cord stimulation protects against atrial fibrillation induced by tachypacingHeart Rhythm, 2012